Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Eplerenone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eplerenone 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eplerenone 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
fosamprenavir 700 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely gemifloxacin mesilate 320 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Gefitinib 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely eletriptan (as eletriptan hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely eletriptan (as eletriptan hydrobromide) 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ethinylestradiol 30 µg + drospirenon 3 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ethinylestradiol 30 µg + drospirenon 3 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Etoricoxib 60 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Etoricoxib 90 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Etoricoxib 120 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Escitalopram (as escitalopram oxalate) 10 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ezetimibe 10 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Escitalopram (as escitalopram oxalate) 20 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dolasetron mesilate 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dolasetron mesilate 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glucosamine 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely glucosamine 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Doxycycline 20 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Conjugated estrogen 900 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Conjugated estrogen 450 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Conjugated estrogen 300 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
clozapin 25 mg tablet oralt opløselig |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
clozapin 100 mg tablet oralt opløselig |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Escitalopram (as escitalopram oxalate) 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Clozapine 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glibenclamide 1.25 mg and metformin hydrochloride 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely glibenclamide 2.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glibenclamide 5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
konjugerede østrogener, 0,3 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,45 mg + medroxyprogesteronacetat 1,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 2,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 2,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
konjugerede østrogener 0,625 mg + medroxyprogesteronacetat 5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Fenofibrate 54 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
fluoxetinhydrochlorid 20 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 250 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glipizide 2.5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Guanidine hydrochloride 125 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely doxercalciferol 2.5 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cinacalcet (as cinacalcet hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Cinacalcet (as cinacalcet hydrochloride) 60 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely cinacalcet (as cinacalcet hydrochloride) 90 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eszopiclone 1 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Eszopiclone 1 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eszopiclone 2 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Eszopiclone 3 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
fosinopril 10 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
fosinopril 20 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
eprosartan 600 mg + hydrochlorthiazid 25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
eprosartan 600 mg + hydrochlorthiazid 25 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
eprosartan 600 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
eprosartan 600 mg + hydrochlorthiazid 12,5 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Difenidol hydrochloride 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely doxercalciferol 500 nanogram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone 250 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dexamethasone 1.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dexamethasone 6 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Fenofibrate 107 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 10 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely dehydroepiandrosterone 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely dehydroepiandrosterone 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dehydroepiandrosterone 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Dimenhydrinate 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Doxylamine 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
emtricitabin 200 mg + tenofovir 136 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
emtricitabin 200 mg + tenofovir 136 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Estradiol acetate 450 microgram oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |